Transformation of the Ukrainian pharmaceutical market – new opportunities and potential Pharmaceutical Industry Review, September No 4 (97) 2023
Table. Rating of corporations: the entire market of medicines, MAT March 2023 / Таблиця. Рейтинг корпорацій: увесь ринок лікарських засобів, MAT за березень 2023 р.
Corporation / Компанія
Farmak / «Фармак»
YURIA-PHARM / «Юрія-Фарм» Darnitsia / «Дарниця» Arterium / «Артеріум» Sanofi / «Санофі» Novartis / «Новартіс» TEVA / «Тева»
Zdorovye Group / «Група Здоров’я» Acino Pharma / Ацино фарма
Kyiv Vitamin Factory / «Київський вітамінний завод»
Kusum Healthcare / Кусум Хелскер KRKA / KRKA
Menarini / Менаріні
Servier Group / Група Серв’є Sinovac / Сіновак
Bayer Healthcare / Bayer Healthcare LEKHIM Group / Група ЛЕКХІМ
Mistral Capital Management / Mistral Capital Management
Novo Nordisk / Novo Nordisk Phizer Incorporated / Phizer Incorporated
Rank / Місце
1 2 3 4 5 6 7 8 9
10 11
12 13 14 15 16 17
18 19
20 MS (UAH%)
5,7% 4,6% 4,5% 3,5% 2,7% 2,6% 2,6% 2,6% 2,6%
2,2% 2,2%
2,1% 2,0% 1,9% 1,9% 1,9% 1,7%
1,7% 1,7%
1,6% GR
-30% -12% 2%
-20% -52% -17% -25% -39% -21%
-11% -24%
228% -32% -23%
-2%
-13% -39%
-25% -26% -18% 228%
EI 93
117 136 106 65
110 100 81
105 118 101
100 98
110 437 91
103 131 115
81
Procurements share / Частка закупівель
27% 70% 32% 31% 4%
28% 3%
43% 4%
2% 2%
1% 1% 8%
100% 12% 7%
79% 31%
44%
is a member of PIC/s. Drug manufacturers have GMP-certified production facilities and the biggest manufacturers export drugs all over the world. It is important to note that after significant fluctuations during the first months of the war, the market share of local manufacturers continued to grow and reached 72.9% in physical terms and 40.3% in monetary terms by the end of the war year. At the same time, the market share in terms of value (UAH) of local manufacturers differs significantly depending on the channel: from 70% in hospital procurement, 42% in regional procurement, 38% in the retail
12 BACK TO CONTENTS
segment, 20% in procurement carried out by the Central Procurement Agency Medical Procurement of Ukraine, up to 2% in central tenders carried out by international procurement organizations. The least number of local manufacturers in centralized purchases is explained by the high share of purchases of patent-protected drugs that are included in nomenclature lists and national programs. Local manufacturers have a higher market share of over-the-counter products (29% in UAHs) compared to imports (24%) and the market average (26%). This share has been generally stable over the past 3 years.
The ranking of the countries of origin also remains quite stable: local manufacturers occupy the 1st
share, Germany and India are consistently in the 2nd
places, despite the decision of some Indian companies to suspend their activities or even leave the Ukrainian market. Chinese manufacturers are regaining market share (mostly due to the vaccine against COVID-19).
Changes in market structure and ratings There were no significant changes in the TOP-10 of the retail market. Farmak kept the lead, and Darnitsia came close to it,
www.promoboz.com
place with a growing market and 3rd
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
